The innovative drug concept continued to strengthen. Haofan Biotech rose or stopped by 20cm, Baili Tianheng rose by more than 10%, and Eddy Pharmaceuticals, Pharmaceutical Kangde, and Zhaoyan New Pharmaceutical had the highest gains.
创新药概念持续走强，昊帆生物20cm涨停
The innovative drug concept continues to strengthen, and Haofan Biotech rises and stops 20 cm
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.